Paper41999136
Molecular cancer prevention: Intercepting disease.
Grieco C and 2 others. Mol Oncol, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Molecular cancer prevention: Intercepting disease. Papers, record 41999136. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41999136
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics5
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Neoplasms | Major topic |
| Humans | |
| Animals | |
| Biomarkers, Tumor | |
| Clinical Trials as Topic |
Source PubMed
Grants20
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| CC2041 | Wellcome Trust | United Kingdom | PubMed | |
| BCRF-23-157 | Breast Cancer Research Foundation | PubMed | ||
| UCL Experimental Cancer Medicine Centre | PubMed | |||
| C11496/A30025 | CRUK Lung Cancer Centre of Excellence | PubMed | ||
| ID16584 | Novo Nordisk | PubMed | ||
| ASPIRE Phase II award (23-034-ASP) | Mark Foundation For Cancer Research | PubMed | ||
| Research Aspire Award (21-029-ASP) | Mark Foundation For Cancer Research | PubMed | ||
| Napier Research Professor RSRP\R\210001 | Royal Society | PubMed | ||
| Professorship Enhancement Award RF\ERE\231118 | Royal Society | PubMed | ||
| RP/EA/180007 | Royal Society | PubMed | ||
| Doctoral Training in AI-enabled Healthcare | UK Research and Innovation | PubMed | ||
| Studentship EP/S021612/1 | UK Research and Innovation | PubMed | ||
| Rosetrees Trust | PubMed | |||
| University College London Hospitals Biomedical Research Centre | PubMed | |||
| ERC Advanced (PROTEUS) 835297 | HORIZON EUROPE European Research Council | PubMed | ||
| CC2041 | Wellcome Trust | United Kingdom | PubMed | |
| CRUK CoL CRTF (SEBCATP-2024/100003) | Cancer Research UK | United Kingdom | PubMed | |
| EDDPMA-Nov21/100034 | Cancer Research UK | United Kingdom | PubMed | |
| PEACE (C416/A21999) | Cancer Research UK | United Kingdom | PubMed | |
| TRACERx (C11496/A17786) | Cancer Research UK | United Kingdom | PubMed |
Source PubMed
References16
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 32025013 | The evolutionary history of 2,658 cancers. | Nature | 2020 | https://conductscience.org/library/papers/32025013 | PubMed |
| 2 | 32744862 | Effects of Interleukin-1β Inhibition on Incident Hip and Knee Replacement : Exploratory Analyses From a Randomized, Double-Blind, Placebo-Controlled Trial. | Ann Intern Med | 2020 | https://conductscience.org/library/papers/32744862 | PubMed |
| 3 | 5279523 | Mutation and cancer: statistical study of retinoblastoma. | Proc Natl Acad Sci U S A | 1971 | https://conductscience.org/library/papers/5279523 | PubMed |
| 4 | 40619604 | Precision Prevention Studies: A Targeted Approach to Cancer Prevention. | Cancer Prev Res (Phila) | 2025 | https://conductscience.org/library/papers/40619604 | PubMed |
| 5 | 37264016 | The blood proteome of imminent lung cancer diagnosis. | Nat Commun | 2023 | https://conductscience.org/library/papers/37264016 | PubMed |
| 6 | 25826379 | UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age. | PLoS Med | 2015 | https://conductscience.org/library/papers/25826379 | PubMed |
| 8 | 37059064 | Impact of risk factors on early cancer evolution. | Cell | 2023 | https://conductscience.org/library/papers/37059064 | PubMed |
| 9 | 28855077 | Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial. | Lancet | 2017 | https://conductscience.org/library/papers/28855077 | PubMed |
| 10 | 38572751 | Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. | CA Cancer J Clin | 2024 | https://conductscience.org/library/papers/38572751 | PubMed |
| 11 | 32989322 | The mutational signature profile of known and suspected human carcinogens in mice. | Nat Genet | 2020 | https://conductscience.org/library/papers/32989322 | PubMed |
| 12 | 38571414 | Advancing Cancer Interception. | Cancer Discov | 2024 | https://conductscience.org/library/papers/38571414 | PubMed |
| 13 | 38970563 | Alternative endpoints to mortality in cancer screening trials. | Mol Oncol | 2024 | https://conductscience.org/library/papers/38970563 | PubMed |
| 14 | 37020004 | Lung adenocarcinoma promotion by air pollutants. | Nature | 2023 | https://conductscience.org/library/papers/37020004 | PubMed |
| 15 | 23060474 | Applying the National Lung Screening Trial eligibility criteria to the US population: what percent of the population and of incident lung cancers would be covered? | J Med Screen | 2012 | https://conductscience.org/library/papers/23060474 | PubMed |
| 16 | 39193459 | Lung cancer screening: where do we stand? | Breathe (Sheff) | 2024 | https://conductscience.org/library/papers/39193459 | PubMed |
| 17 | 37788412 | Canakinumab as Adjuvant Therapy in Patients With Completely Resected Non-Small-Cell Lung Cancer: Results From the CANOPY-A Double-Blind, Randomized Clinical Trial. | J Clin Oncol | 2024 | https://conductscience.org/library/papers/37788412 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 0 citations.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 42842193 | Precision Cancer Prevention - Research Promise and Education Needs. | J Cancer Educ | 2026 | https://conductscience.org/library/papers/42842193 |
Source PubMed
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41999136
GET https://conductscience.org/api/papers/v1/41999136/authors